In the treatment of multiple myeloma cells with bortezomib and gambogenic acid, a prenylated xanthone was observed to induce apoptosis via the activation of PARP cleavage, P53, Caspase-3 cleavage and Bax and inhibition of Bcl-2 expression (172). Here, TP53 is linked to plasma cell myeloma.